Wall Street Cuts Mosaic Again: UBS Slashes Target to $27
UBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
Assess tax efficiency between index funds and target-date funds, including distributions and potential tax-optimized strategies for investors.
28,288 articlesUBS cuts Mosaic’s price target to $27, citing squeezed phosphate margins from higher sulfur and input costs, as Wall ...
A major biotech takeover bid sets the tone for today’s market. AbbVie’s cash offer for Apogee Therapeutics sent share...
Alphabet unveiled a record $84.75B equity sale to fuel AI infrastructure. The move sent ripples through the stock mar...
When a tech titan reshuffles its gaming division, investors pay attention. This article breaks down the potential sto...
Two iconic brands face different paths to recovery. This deep-dive weighs Nike 12-Year and Lululemon 8-Year dynamics,...
In a market facing higher-rate reality and volatile swings, retirees increasingly prefer steady cash flows from incom...
One prominent chartist argues XRP could surge to $42 by 2026, but rivals say the move would require unprecedented ins...
Oracle has faced skepticism around AI spending and cloud growth. This article digs into how Oracle's AI-Fueled Growth...
Hypernova has closed a $3 million pre-seed round to bring a hyperliquid-based prop trading platform to market, promis...
Vertex Pharmaceuticals just made aBold move that could reshape its growth trajectory. This guide breaks down the deal...
NCS Multistage's Q4 2025 earnings call offers insight into margins, backlog, and growth drivers. This guide translate...
If you’re tracking Lumentum stock, a major update could redefine the risk and reward. This article explains what huge...